• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪便钙卫蛋白和乳铁蛋白与克罗恩病内镜评分及组织学结果的相关性

Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings.

作者信息

Sipponen T, Kärkkäinen P, Savilahti E, Kolho K-L, Nuutinen H, Turunen U, Färkkilä M

机构信息

Division of Gastroenterology, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland.

出版信息

Aliment Pharmacol Ther. 2008 Nov 15;28(10):1221-9. doi: 10.1111/j.1365-2036.2008.03835.x. Epub 2008 Aug 26.

DOI:10.1111/j.1365-2036.2008.03835.x
PMID:18752630
Abstract

BACKGROUND

Faecal calprotectin and lactoferrin increasingly serve as surrogate markers of disease activity in IBD. Data on the correlation of these markers with simple endoscopic score for Crohn's disease (SES-CD) and with histological findings are as yet limited. Aim To study the correlation of faecal calprotectin and lactoferrin with SES-CD and histology.

METHODS

During 87 consecutive ileocolonoscopies, SES-CD was calculated and biopsy specimens were obtained from the ileum, colon and rectum. Faecal calprotectin and lactoferrin were measured.

RESULTS

In ileocolonic or colonic disease, both faecal calprotectin and lactoferrin correlated significantly with colon SES-CD (P < 0.001) and colon histology (P < 0.001). In patients with normal calprotectin or lactoferrin levels, endoscopic and histology scores were significantly lower than in those with elevated concentrations (P < 0.001). In ileal CD, ileal SES-CD correlated with histology (P < 0.001), but not with faecal calprotectin (P = 0.161) or lactoferrin (P = 0.448).

CONCLUSION

In ileocolonic and colonic disease, endoscopic score SES-CD and histological findings correlated significantly with faecal calprotectin and lactoferrin. A normal faecal-marker concentration was a reliable surrogate marker for endoscopically and histologically inactive CD. Ileal endoscopic score and histological findings failed, however, to correlate with faecal markers.

摘要

背景

粪便钙卫蛋白和乳铁蛋白越来越多地作为炎症性肠病(IBD)疾病活动的替代标志物。关于这些标志物与克罗恩病简单内镜评分(SES-CD)及组织学结果之间相关性的数据仍然有限。目的:研究粪便钙卫蛋白和乳铁蛋白与SES-CD及组织学的相关性。

方法

在连续87例回结肠镜检查过程中,计算SES-CD并从回肠、结肠和直肠获取活检标本。检测粪便钙卫蛋白和乳铁蛋白。

结果

在回结肠或结肠疾病中,粪便钙卫蛋白和乳铁蛋白均与结肠SES-CD(P < 0.001)及结肠组织学(P < 0.001)显著相关。在钙卫蛋白或乳铁蛋白水平正常的患者中,内镜和组织学评分显著低于浓度升高的患者(P < 0.001)。在回肠克罗恩病中,回肠SES-CD与组织学相关(P < 0.001),但与粪便钙卫蛋白(P = 0.161)或乳铁蛋白(P = 0.448)无关。

结论

在回结肠和结肠疾病中,内镜评分SES-CD及组织学结果与粪便钙卫蛋白和乳铁蛋白显著相关。粪便标志物浓度正常是内镜及组织学上无活动的克罗恩病的可靠替代标志物。然而,回肠内镜评分和组织学结果与粪便标志物无相关性。

相似文献

1
Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings.粪便钙卫蛋白和乳铁蛋白与克罗恩病内镜评分及组织学结果的相关性
Aliment Pharmacol Ther. 2008 Nov 15;28(10):1221-9. doi: 10.1111/j.1365-2036.2008.03835.x. Epub 2008 Aug 26.
2
Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.粪便钙卫蛋白与克罗恩病简单内镜评分(SES-CD)的相关性比 CRP、血白细胞和 CDAI 更密切。
Am J Gastroenterol. 2010 Jan;105(1):162-9. doi: 10.1038/ajg.2009.545. Epub 2009 Sep 15.
3
Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease.克罗恩病患者疾病活动与血清及粪便生物标志物之间的关系。
Clin Gastroenterol Hepatol. 2008 Nov;6(11):1218-24. doi: 10.1016/j.cgh.2008.06.010. Epub 2008 Sep 17.
4
Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment.粪便钙卫蛋白和乳铁蛋白是克罗恩病治疗期间内镜反应的可靠替代标志物。
Scand J Gastroenterol. 2010 Mar;45(3):325-31. doi: 10.3109/00365520903483650.
5
Faecal calprotectin in the assessment of Crohn's disease activity.粪便钙卫蛋白在克罗恩病活动度评估中的应用
QJM. 2005 Jun;98(6):435-41. doi: 10.1093/qjmed/hci069. Epub 2005 May 6.
6
Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease.克罗恩病回结肠切除术后的粪便乳铁蛋白和钙卫蛋白
Dis Colon Rectum. 2007 Jun;50(6):861-9. doi: 10.1007/s10350-007-0225-6.
7
Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.炎症性肠病中肠道炎症评估的非侵入性标志物:粪便乳铁蛋白、钙卫蛋白、PMN弹性蛋白酶、CRP及临床指标的表现
Am J Gastroenterol. 2008 Jan;103(1):162-9. doi: 10.1111/j.1572-0241.2007.01556.x. Epub 2007 Oct 4.
8
Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease.粪便钙卫蛋白或乳铁蛋白可识别克罗恩病术后复发情况。
Br J Surg. 2009 Jun;96(6):663-74. doi: 10.1002/bjs.6593.
9
Impact of disease location on fecal calprotectin levels in Crohn's disease.疾病部位对克罗恩病粪便钙卫蛋白水平的影响。
Scand J Gastroenterol. 2015 Jul;50(7):841-7. doi: 10.3109/00365521.2015.1008035. Epub 2015 Jan 30.
10
Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.粪便钙卫蛋白作为评估炎症性肠病患儿黏膜炎症严重程度的可靠非侵入性标志物。
Dig Liver Dis. 2008 Jul;40(7):547-53. doi: 10.1016/j.dld.2008.01.017. Epub 2008 Mar 20.

引用本文的文献

1
A phase 1b clinical trial to determine the safety, tolerability and immunogenicity of simian adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies in patients with active Crohn's disease.一项1b期临床试验,旨在确定猿猴腺病毒和痘病毒载体疫苗针对活动性克罗恩病患者鸟分枝杆菌复合群亚种的安全性、耐受性和免疫原性。
EBioMedicine. 2025 Mar;113:105570. doi: 10.1016/j.ebiom.2025.105570. Epub 2025 Feb 7.
2
A Simple Endoscopic Score for Crohn's Disease (SES-CD) ≥ 7 Predicts Disease Progression.克罗恩病简易内镜评分(SES-CD)≥7预示疾病进展。
Aliment Pharmacol Ther. 2025 Mar;61(6):1011-1018. doi: 10.1111/apt.18492. Epub 2025 Jan 5.
3
Fecal Leukocyte Esterase, an Alternative Biomarker to Fecal Calprotectin in Inflammatory Bowel Disease: A Pilot Series.
粪便白细胞酯酶:炎症性肠病中粪便钙卫蛋白的替代生物标志物——一项初步系列研究
Gastro Hep Adv. 2022 Feb 3;1(1):45-51. doi: 10.1016/j.gastha.2021.10.006. eCollection 2022.
4
Fecal calprotectin and endoscopic scores: The cornerstones in clinical practice for evaluating mucosal healing in inflammatory bowel disease.粪便钙卫蛋白和内镜评分:炎症性肠病黏膜愈合评估的临床实践基石。
World J Gastroenterol. 2024 Jun 28;30(24):3022-3035. doi: 10.3748/wjg.v30.i24.3022.
5
Treat to target in Crohn's disease: A practical guide for clinicians.《靶向治疗克罗恩病:临床医生实用指南》
World J Gastroenterol. 2024 Jan 7;30(1):50-69. doi: 10.3748/wjg.v30.i1.50.
6
Selected Cytokines and Metalloproteinases in Inflammatory Bowel Disease.炎症性肠病中的精选细胞因子和金属蛋白酶。
Int J Mol Sci. 2023 Dec 22;25(1):202. doi: 10.3390/ijms25010202.
7
Personalized Treatment for Crohn's Disease: Current Approaches and Future Directions.克罗恩病的个性化治疗:当前方法与未来方向
Clin Exp Gastroenterol. 2023 Dec 14;16:249-276. doi: 10.2147/CEG.S360248. eCollection 2023.
8
Monitoring of Inflammatory Bowel Disease in Pregnancy: A Review of the Different Modalities.孕期炎症性肠病的监测:不同方式综述
J Clin Med. 2023 Nov 27;12(23):7343. doi: 10.3390/jcm12237343.
9
Assessment of Ileal Crohn's Disease Activity by Gastrointestinal Ultrasound and MR Enterography: A Pilot Study.通过胃肠道超声和磁共振小肠造影评估回肠克罗恩病活动度:一项初步研究。
Life (Basel). 2023 Aug 16;13(8):1754. doi: 10.3390/life13081754.
10
Fecal Biomarkers of Neutrophil and Eosinophil Origin Reflect the Response to Biological Therapy and Corticosteroids in Patients With Inflammatory Bowel Disease.粪便中中性粒细胞和嗜酸性粒细胞来源的生物标志物反映了炎症性肠病患者对生物治疗和皮质类固醇的反应。
Clin Transl Gastroenterol. 2023 Aug 1;14(8):e00605. doi: 10.14309/ctg.0000000000000605.